课题基金 / 基金详情

Impact of Smoking on Lung Cancer Chemoprevention

Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
批准号:
6949040
负责人:
Waun Ki Hong
金额:
$172.88万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-20 至 2008-07-31

项目摘要

项目成果

Waun Ki Hong的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant) Lung cancer is the leading cause of cancer death among both men and women in the United States today, and a rising public health problem throughout the world. Although we?ve seen some improvement using combined modality approaches, these have had little impact on survival. Chemoprevention is a highly promising new approach that has already shown enormous potential for the control of other epithelial solid tumors. However, numerous studies of lung cancer chemoprevention have shown no benefit, and some have shown actual harmful effects in current smokers. It seems clear that previously unsuspected adverse interactions exist between tobacco carcinogens and chemopreventive agents. Although further studies of lung cancer chemoprevention are warranted, a thorough investigation of these carcinogen/chemoprevention interactions is necessary before further large-scale randomized trials are implemented. The overall goals of this translational, multidisciplinary Program project are to elucidate the interactions between tobacco carcinogens and chemopreventive agents, investigate the potential of celecoxib for lung cancer chemoprevention, and validate intermediate markers of lung carcinogenesis. To accomplish our goals, we propose to carry out a clinical chemoprevention trial in humans, while performing genetic, molecular, and pharmacologic studies to understand the carcinogenic process and the interaction of carcinogens with chemopreventive agents through the following projects: Project 1: Clinical Trial of Celecoxib in Lung Cancer Chemoprevention Project 2: Lung Cancer Prevention by COX-2 and 5-LOX Inhibitors, Retinoids, and Their Combinations Project 3: Molecular Alterations in Lung Carcinogenesis Project 4: The Role of Transcription Factor NF-kB in Lung Cancer Development and Chemoprevention Core components (Administration, Biostatistics and Data Management, Histology, and Pharmacology) are also included to provide the structure and expertise required for the successful integration and execution of these studies.
期刊论文(135)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1535-7163.mct-09-1113
发表时间: 2010-04
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Prasad S, Ravindran J, Sung B, Pandey MK, Aggarwal BB]
通讯作者: Aggarwal BB
Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
通过小分子抑制 NF-κB 激活作为治疗策略。
DOI: 10.1016/j.bbagrm.2010.05.004
发表时间: 2010-10
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子: 4.7
作者: [Gupta, Subash C., Sundaram, Chitra, Reuter, Simone, Aggarwal, Bharat B.]
通讯作者: Aggarwal, Bharat B.
Biological activity of celecoxib in the bronchial epithelium of current and former smokers.
塞来昔布在当前和前吸烟者的支气管上皮中的生物学活性。
DOI: 10.1158/1940-6207.capr-09-0233
发表时间: 2010-02
期刊: Cancer prevention research (Philadelphia, Pa.)
影响因子: --
作者: [Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD, Jimenez CA, Eapen GA, Lotan R, Tang X, Newman RA, Wistuba II, Kurie JM]
通讯作者: Kurie JM
DOI: 10.1158/1535-7163.mct-08-0905
发表时间: 2009-04
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S, Aggarwal BB]
通讯作者: Aggarwal BB
40
    MD Anderson Cancer Center SPORE in Head and Neck Cancer
    MD Anderson Cancer Center SPORE in Head and Neck Cancer
    MD Anderson Cancer Center SPORE in Head and Neck Cancer
    MD Anderson Cancer Center SPORE in Head and Neck Cancer